CompletedNot applicableNCT04543968

Clinical Study of Hydroxytyrosol (HT) in Mitochondrial Diseases

Studying Mitochondrial disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hong Kong Children's Hospital
Principal Investigator
Cheuk Wing Fung
Hong Kong Children's Hospital
Intervention
hydroxytyrosol (HT) intake(dietary_supplement)
Enrollment
10 enrolled
Eligibility
3-18 years · All sexes
Timeline
20222024

Study locations (1)

Collaborators

The University of Hong Kong

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04543968 on ClinicalTrials.gov

Other trials for Mitochondrial disease

Additional recruiting or active studies for the same condition.

See all trials for Mitochondrial disease

← Back to all trials